Delivery Order SPE2DR25D3104-SPE2DR26FE9EQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,545.85 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. This order, issued on November 20, 2025, with completion targeted for November 21, 2025, represents a firm fixed price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designations, reflecting open...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,388.84 to supply Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,162.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract, which carried no set-aside designation, was fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,133.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (unit dose, 10-count packaging) on January 6, 2026, with completion targeted for January 7, 2026. The award was made without set-aside restrictions through open competition. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order valued at $1,716.12 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (100-count units) with a completion date of December 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this...
- The Defense Logistics Agency awarded a delivery order valued at $2,081.00 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s) on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $7,699.70 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10s. This contract, awarded on December 19, 2025, represents a firm fixed price delivery order with an ultimate completion date of December 22, 2025. The award is non-set-aside and competitively awarded, with performance to be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,373.02 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. The contract, awarded on December 29, 2025, with an ultimate completion date of December 30, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,440.33 for Oseltamivir Phosphate 30 mg capsules in unit dose packaging of 10s, with an ultimate completion date of December 23, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE9EQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,684.75 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules (100-count units) on January 6, 2026, with completion expected by January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The contract supports critical federal medical institutions including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/5/26 |